evidence for carcinogenic chromium(vi) compounds in chromium(iii) treated living cells /

Published at 2016-01-05 12:40:18

Home / Categories / Biochemistry / evidence for carcinogenic chromium(vi) compounds in chromium(iii) treated living cells
Chromium supplements are widely consumed for their antidiabetic activity as chromium(III) enhances the insulin sensitivity of cells. In specific,orthomolecular practitioners believe in the favourable effects of providing the body with extra amounts of fundamental trace elements. As Australian and American scientists now report in the journal Angewandte Chemie, chromium(III) dietary supplements are oxidized to a certain extent in living cells to their carcinogenic and genotoxic chromium(V) and chromium(VI) counterparts, or which raises questions about potential risks of such therapies.

Source: phys.org

Warning: Unknown: write failed: No space left on device (28) in Unknown on line 0 Warning: Unknown: Failed to write session data (files). Please verify that the current setting of session.save_path is correct (/tmp) in Unknown on line 0